July 24, 2014

Local residents, tourists and attendees of Cardinal Health’s annual Retail Business Conference battled the heat and gathered at the National Mall in Washington, D.C., on Wednesday to enjoy the Health on the National Mall event, co-sponsored by Cardinal Health and the National Community Pharmacists Association.

July 23, 2014

McKesson Pharmacy Systems and Automation launched its new Adherence Performance reporting tool, which uses pharmacy data to supply pharmacies with the data they need to make improvements on the adherence of their patient base, the company said.

July 22, 2014

“You have to be willing to do what your competition is not willing to do.” That was one of the key messages from motivational speaker and Olympic speed skier Vince Poscente, which also tied into the message Steve Courtman, president of Health Mart, and Tony Willoughby, Health Mart chief pharmacist, had for attendees at Tuesday morning’s Health Mart Annual Meeting.

July 22, 2014

Tuesday morning’s Health Mart Annual Meeting provided franchisee members with an overview of recent investments in the franchise and McKesson’s plans to “help level the playing field” for independent pharmacies through new programs that improve patient outcomes and pharmacy efficiency, as well as more flexible and local marketing efforts.

July 22, 2014

Fresh from Tuesday morning’s Health Mart Annual Meeting at 2014 McKesson ideaShare, attendees eagerly gathered to take part in the Health Mart University Live sessions that addressed key topics for independent pharmacy success.

July 22, 2014

After speaking at the Health Mart Annual Meeting Tuesday morning, Tony Willoughby, Health Mart’s chief pharmacist, sat down with DSN to talk about how pharmacies can drive adherence and excel in today’s changing healthcare environment.

July 21, 2014

Even before the official start of this year’s McKesson ideaShare conference, the Gaylord Palms Resort and Convention Center was buzzing with attendees eager to take advantage of the robust lineup of continuing education courses held on Sunday and Monday.

July 21, 2014

This year’s McKesson ideaShare 2014 kicked off with a bang as thousands of community pharmacy leaders flocked to Orlando, Fla., to participate in the annual event and seize the opportunities to grow in today’s changing healthcare landscape.

July 21, 2014

The new KL1Plus double counts the tablets it dispenses and can then store the count data for up to 10 years.

July 21, 2014

The Food and Drug Administration’s Center for Drug Evaluation and Research is providing an update to key leadership positions within the Office of Generic Drugs, the agency announced.

July 18, 2014

FedEx on Thursday was indicted as a co-conspirator for illegally distributing pharmaceuticals sourced from a pair of rogue online pharmacies.

 

July 17, 2014

Purdue Pharma announced that the Food and Drug Administration approved a new 7.5-mcg/hour dosage strength of Butrans (buprenorphine) transdermal system CIII.

July 17, 2014

About 30% of top-performing OTC drugs today were once prescription-only medications noted Dave Wendland, VP Hamacher Resource Group, on Thursday during a videocast hosted by GMDC titled "Rx-to-OTC: Getting it Right at Retail."

July 17, 2014

Mylan on Thursday announced that the U.S. District Court for the district of New Jersey granted its motion for a permanent injunction against GlaxoSmithKline in relation to paroxetine CR, the generic version of GSK's Paxil CR.

July 16, 2014

Sun Life Assurance Company of Canada entered into a strategic business relationship with McKesson Canada to launch the Sun Life Preferred Pharmacy Network.

July 16, 2014

RetireSafe, a grassroots organization advocating on behalf of America’s seniors on Tuesday released a survey finding that seniors overwhelmingly support strong patient safeguards for biosimilar medications. 

July 15, 2014

Giant Eagle last week added prescription blood-pressure medications lisinopril and lisinopril HCTZ to the list of several antibiotics that the chain provides for free to its patients, according to a report in the Columbus Dispatch

July 14, 2014

In an effort to battle medication non-adherence, regional player Kinney Drugs has unveiled its new EZSync program to synchronize pickup dates and prescription refills.

July 14, 2014

Although the pace of approvals for new orphan drugs — medicines that treat relatively rare conditions — have increased in the United States and Europe in recent years, patients are facing growing challenges accessing those drugs, a newly completed study released last week by the Tufts Center for the Study of Drug Development at Tufts University has concluded.

July 11, 2014

Anacor Pharmaceuticals announced that the Food and Drug Administration has approved the company's new drug application for Kerydin (tavaborole) topical solution, 5% — an antifungal approved for the topical treatment of onychomycosis of the toenails.

July 10, 2014

Ateb on Thursday announced it has reached an agreement to license Walgreens' entire portfolio of prescription alignment patents in an effort to continue to improve overall health care, demonstrate the value of medication synchronization and increase patient adherence rates.

July 10, 2014

With community pharmacies being called on to provide a wider range of services, drug stores across the country are adapting new technologies to ensure that they can meet the evolving needs of their patients and strengthen their role in the nation’s healthcare system.

July 10, 2014

As lifetime earnings for pharmaceuticals decrease, commercialization expenses increase and payers tighten their belts on reimbursement, life science companies will be faced with shrinking margins over the next few years. In order to maintain basic operating margin levels and continue investing in research and development at current levels, life science manufacturers will be forced to reduce costs by more than $35 billion by 2017, according to results from a new survey of 70 life science organizations from the IMS Institute for Healthcare Informatics.

July 10, 2014

The Food and Drug Administration in late June issued a warning letter to Zarbee's for making therapeutic claims regarding a dietary supplement product.